TREA

Giles Albert Brown

Follow

Person

  • Welwyn Garden City, GB
People

Patents Grantslast 30 patents

Patents Applicationslast 30 patents

  • Information Patent Application

    H4 Antagonist Compounds
    • Publication number 20240317775
    • Publication date Sep 26, 2024
    • Giles Albert BROWN
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    ORAL GLP RECEPTOR AGONISTS
    • Publication number 20240270809
    • Publication date Aug 15, 2024
    • Heptares Therapeutics Limited
    • Giles Albert BROWN
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    GPR35 Agonist Compounds
    • Publication number 20240254093
    • Publication date Aug 1, 2024
    • Heptares Therapeutics Limited
    • Miles Stuart CONGREVE
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    CYCLIC APELIN RECEPTOR AGONISTS
    • Publication number 20230382950
    • Publication date Nov 30, 2023
    • Heptares Therapeutics Limited
    • Giles Albert BROWN
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    LINEAR APELIN RECEPTOR AGONISTS
    • Publication number 20230382949
    • Publication date Nov 30, 2023
    • Heptares Therapeutics Limited
    • Giles Albert BROWN
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    GLP RECEPTOR AGONISTS
    • Publication number 20230295260
    • Publication date Sep 21, 2023
    • Heptares Therapeutics Limited
    • Giles Albert Brown
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    GLP-1 RECEPTOR ANTAGONISTS
    • Publication number 20230279053
    • Publication date Sep 7, 2023
    • Heptares Therapeutics Limited
    • Giles Albert Brown
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    5-AMINO-8-(4-PYRIDYL)-[1,2,4]TRIAZOLO[4,3-C]PYRIMIDIN-3-ONE COMPOUN...
    • Publication number 20230271964
    • Publication date Aug 31, 2023
    • AstraZeneca AB
    • Giles Albert Brown
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    5-AMINO-8-(4-PYRIDYL)-[1,2,4]TRIAZOLO[4,3-C]PYRIMIDIN-3-ONE COMPOUN...
    • Publication number 20230146483
    • Publication date May 11, 2023
    • AstraZeneca AB
    • Giles Albert Brown
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    TRIAZOLONE COMPOUNDS
    • Publication number 20230146796
    • Publication date May 11, 2023
    • AstraZeneca AB
    • Giles Albert Brown
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    1,2,4-TRIAZINE-4-AMINE DERIVATIVES
    • Publication number 20230021177
    • Publication date Jan 19, 2023
    • Heptares Therapeutics Limited
    • Miles Stuart Congreve
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    MUSCARINIC AGONISTS
    • Publication number 20230002354
    • Publication date Jan 5, 2023
    • Heptares Therapeutics Limited
    • Giles Albert Brown
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    CXCR4 Receptor Antagonists
    • Publication number 20220348577
    • Publication date Nov 3, 2022
    • Proximagen, LLC
    • Giles BROWN
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    CGRP ANTAGONIST COMPOUNDS
    • Publication number 20220306651
    • Publication date Sep 29, 2022
    • Heptares Therapeutics Limited
    • Giles Albert Brown
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    OXIME COMPOUNDS AS AGONISTS OF THE MUSCARINIC M1 AND/OR M4 RECEPTOR
    • Publication number 20220298133
    • Publication date Sep 22, 2022
    • Heptares Therapeutics Limited
    • Giles Albert Brown
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    CGRP ANTAGONIST COMPOUNDS
    • Publication number 20220251110
    • Publication date Aug 11, 2022
    • Heptares Therapeutics Limited
    • Giles Albert Brown
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    SUBSTITUTED CYCLOHEXANES AS MUSCARINIC M1 RECEPTOR AND/OR M4 RECEPT...
    • Publication number 20220213034
    • Publication date Jul 7, 2022
    • Heptares Therapeutics Limited
    • Giles Albert Brown
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    OXEXIN 1 RECEPTOR ANTAGONISTS
    • Publication number 20220098165
    • Publication date Mar 31, 2022
    • Heptares Therapeutics Limited
    • Giles Albert Brown
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    MUSCARINIC RECEPTOR AGONISTS
    • Publication number 20220048928
    • Publication date Feb 17, 2022
    • Heptares Therapeutics Limited
    • Miles Stuart Congreve
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    OREXIN 1 RECEPTOR ANTAGONISTS
    • Publication number 20220041573
    • Publication date Feb 10, 2022
    • Heptares Therapeutics Limited
    • Giles Albert Brown
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    QUINOLINONE AND BENZOXAZINE DERIVATIVES AS MUSCARINIC M1 AND/OR M4...
    • Publication number 20220017504
    • Publication date Jan 20, 2022
    • Heptares Therapeutics Limited
    • Giles Albert Brown
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    BICYCLIC AZA COMPOUNDS AS MUSCARINIC M1 AND/OR M4 RECEPTOR AGONISTS
    • Publication number 20210387969
    • Publication date Dec 16, 2021
    • Heptares Therapeutics Limited
    • Giles Albert Brown
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    CYCLOHEXAPEPTIDES AS SELECTIVE SOMATOSTATIN SST5 RECEPTOR AGONISTS
    • Publication number 20210363188
    • Publication date Nov 25, 2021
    • Heptares Therapeutics Limited
    • Giles Albert Brown
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    MUSCARINIC M1 RECEPTOR AGONISTS
    • Publication number 20210353637
    • Publication date Nov 18, 2021
    • Heptares Therapeutics Limited
    • Miles Stuart Congreve
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    GLP-1 RECEPTOR ANTAGONISTS
    • Publication number 20210355186
    • Publication date Nov 18, 2021
    • Heptares Therapeutics Limited
    • Giles Albert Brown
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    PYRAZOLE DERIVATIVES AS H4 ANTAGONIST COMPOUNDS
    • Publication number 20210300906
    • Publication date Sep 30, 2021
    • Heptares Therapeutics Limited
    • Giles Albert Brown
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    OX1 ANTAGONISTS
    • Publication number 20210179578
    • Publication date Jun 17, 2021
    • Heptares Therapeutics Limited
    • John Andrew Christopher
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    PHARMACEUTICAL COMPOUNDS
    • Publication number 20210101893
    • Publication date Apr 8, 2021
    • Heptares Therapeutics Limited
    • Giles Albert Brown
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    PHARMACEUTICAL COMPOUNDS
    • Publication number 20210040067
    • Publication date Feb 11, 2021
    • Heptares Therapeutics Limited
    • Giles Albert Brown
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    PHARMACEUTICAL COMPOUNDS
    • Publication number 20210002271
    • Publication date Jan 7, 2021
    • Heptares Therapeutics Limited
    • Giles Albert Brown
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE